Does Wegovy Cause Constipation?

Published May 25, 2026Updated May 27, 2026Last reviewed May 25, 2026

For the broader cluster context, see the semaglutide side effects and safety hub.

Author: HealthRX Editorial Team Medically reviewed by: Dr. Mark Halpern, MD (Internal Medicine, Obesity Medicine) Last clinical review: May 2026

Compounded semaglutide is not FDA-approved. This article is patient education and does not replace consultation with a licensed clinician.

Denise, 44, an office manager in Tucson, started compounded semaglutide in February at the 0.25 mg dose. By week three, she hadn't had a bowel movement in five days. "I expected the nausea," she told her clinician during a follow-up call. "Nobody warned me I'd feel like I swallowed a brick." Her prescriber bumped her water target to 80 ounces a day, added 28 grams of soluble fiber, and within four days things were moving again. She never needed a dose adjustment.

Denise's experience is boringly typical. Constipation is one of the most common, most predictable, and most manageable side effects on semaglutide. The short answer to "does Wegovy cause constipation?" is yes, frequently. The longer answer involves understanding why it happens and what to do about it before it becomes a problem.

This guide sits inside the broader Compounded Semaglutide Side Effects and Safety cluster, which is part of the compounded semaglutide pillar guide.

The Trial Data, Plainly

The clinical trial program for semaglutide is unusually large by obesity medicine standards. Across STEP-1, STEP-3, STEP-4, SUSTAIN-6, LEADER, and SELECT, gastrointestinal symptoms were the most commonly reported adverse effects, and serious adverse events were uncommon.

Here's the thing about constipation specifically: it doesn't get the headline attention that nausea does, but it shows up consistently. In STEP-1, roughly 20 percent of patients reported nausea at some point, and constipation trailed not far behind. Most GI side effects followed a predictable arc: they appeared at or shortly after a dose increase, peaked in intensity over the first week or two, and then faded.

The label for Wegovy and Ozempic includes a boxed warning regarding thyroid C-cell tumors based on rodent data. Human evidence for that risk has not materialized at population scale in the large outcome trials. Most prescribers screen for personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 before writing the prescription. Pancreatitis was reported in a small fraction of patients across these trials, with rates that did not differ significantly between active and placebo arms in SELECT or LEADER, though individual cases always warrant attention.

Why Your Gut Slows Down

Think of semaglutide's effect on your digestive tract like putting a speed governor on a conveyor belt. The drug slows gastric emptying and reduces transit time through the intestines. That's actually the point: the slower movement is part of how the medication generates the fullness signal that reduces appetite. Your gut doesn't distinguish between "helpful pharmacologic effect" and "side effect." It's the same mechanism doing both things.

The second piece is behavioral and almost always overlooked. When people eat less, they drink less. It's instinctive. You're not sitting down to meals as often, you're not reaching for a glass of water alongside a plate of food. Less fluid in means harder, drier stool. Less food volume also means less bulk moving through the colon, which reduces the mechanical stimulus for peristalsis.

So you've got two forces working in the same direction: the drug slowing transit, and reduced intake giving the colon less to work with. No wonder constipation is common.

What Actually Helps

The first-line fixes are unsexy but effective:

Hydration. Most clinical references for GLP-1 patients suggest roughly half an ounce of water per pound of body weight per day. For a 180-pound person, that's 90 ounces. If you're coming from a baseline of 40 or 50 ounces (most people are), that's a real change in habit.

Fiber. The target is 25 to 35 grams per day from food, with emphasis on soluble fiber: oats, chia seeds, cooked vegetables, beans if tolerated. Fiber supplements work too, but food-based fiber tends to be gentler.

Small, slow, lower-fat meals. During the first two weeks after any dose change, avoiding very rich or fried food reduces the overall GI burden. This isn't permanent dietary restriction. It's a transitional strategy.

Osmotic laxatives (like MiraLAX) are appropriate as a short-term tool when dietary adjustments alone aren't enough. They're routine in the toolkit and nothing to feel weird about. Your clinician can prescribe or recommend one.

The boring truth is that most constipation on semaglutide resolves with these four interventions. It doesn't require a dose reduction. It doesn't require stopping the medication. It requires drinking more water and eating more fiber, which are things most Americans should be doing regardless.

When to Actually Worry

The threshold for calling your prescriber should be lower than you think. Constipation lasting more than a week despite adequate hydration and fiber is worth a call. Constipation accompanied by severe abdominal pain, vomiting, or bloating that feels different from your baseline is worth a call. And constipation is not the only possible explanation for those symptoms. Your clinician needs to consider other diagnoses.

More broadly: vomiting lasting more than a day, severe upper abdominal pain (especially if it radiates to the back), signs of dehydration, jaundice, persistent severe headache, or vision changes all warrant prompt contact. Most GI side effects never approach this territory, but you should know the thresholds.

Does Side Effect Intensity Mean the Drug Is "Working"?

No. This is one of the most persistent myths in the GLP-1 patient community, and the data don't support it. Patients in STEP-1 and STEP-3 with mild GI side effects achieved meaningful weight loss at the same rates as patients with more pronounced symptoms. Suffering through nausea or constipation is not a badge of efficacy. If your side effects are manageable, that's good news, not a sign the drug isn't doing its job.

Compounded Semaglutide: Same Molecule, Different Regulatory Path

The active ingredient in compounded semaglutide preparations is the same molecule as in Wegovy and Ozempic. The clinical evidence base for that molecule (everything cited in this article) therefore applies to the compounded form. Where things diverge is regulatory status. Compounded semaglutide is prepared by licensed 503A or 503B compounding pharmacies under a clinician's prescription. It is not FDA-approved. It has not been independently studied in randomized trials at the same scale as the branded products. The oversight framework is different.

This distinction matters, and patients should understand it. But it doesn't change the pharmacology of constipation. If you're on compounded semaglutide and experiencing slow bowels, the same mechanisms are at work and the same interventions apply.

One thing I'll say directly: the quality of your clinical relationship matters more than the brand on the vial. A program that responds to side effects with timely adjustments, checks in between refills, and treats your symptoms as real clinical data will produce better outcomes than one that sends you a tracking app and disappears. That's true for constipation and for every other aspect of GLP-1 therapy.

The STEP-4 Lesson About Duration

A point worth making here, because it changes how patients think about side effect management. STEP-4 documented partial weight regain over 48 weeks after participants switched from active semaglutide to placebo at week 20. The biology of weight regulation reasserts itself when pharmacologic support is removed, similar to how blood pressure trends upward again when antihypertensives are discontinued.

The implication for constipation: if you're going to be on this medication for the long term (and the data suggest many patients will benefit from extended use), then building sustainable hydration and fiber habits isn't just a workaround for a temporary side effect. It's a permanent upgrade to how you eat and drink. The patients who do best are the ones who treat the first few months of GI adjustment as a training period for habits they'll keep.

STEP-3, which paired semaglutide with a structured lifestyle intervention, produced greater mean weight loss than STEP-1, which used the medication with standard counseling. Lifestyle is additive. It is not optional for durable outcomes.

Adjacent Reading

Where This Fits

This article is part of the Compounded Semaglutide Side Effects and Safety cluster. For a broader treatment of the molecule, the regulatory pathway, the 503A and 503B compounding framework, and the clinical evidence base, the compounded semaglutide pillar guide is the primary reference on this site.

Frequently Asked Questions

Are the side effects of compounded semaglutide different from Wegovy or Ozempic?

The active ingredient is the same molecule, and the side effect profile reported in compounded semaglutide programs mirrors what was reported in SUSTAIN, STEP-1, and STEP-3 for the branded products. Compounded preparations are not FDA-approved and have not been independently studied in the same way.

When should a side effect trigger a call to the prescriber?

Severe abdominal pain, persistent vomiting, signs of dehydration, jaundice, or vision changes are reasons to contact the prescribing clinician promptly. For constipation specifically, call if it persists beyond a week despite hydration and fiber, or if it's accompanied by significant pain.

Do side effects predict effectiveness?

No. There is no reliable evidence that nausea, constipation, or other GI side effects predict greater weight loss. Trial data show meaningful results in patients with minimal side effects as well as those with more.

How long does constipation typically last after a dose increase?

For most patients, GI side effects (including constipation) peak in the first one to two weeks after a dose change and then improve. Patients who maintain adequate hydration and fiber often find it resolves faster.

Is it safe to use over-the-counter laxatives while on semaglutide?

Osmotic laxatives like polyethylene glycol (MiraLAX) are commonly recommended by prescribers for short-term use. Stimulant laxatives should generally be discussed with your clinician first, as they work through a different mechanism and aren't ideal for routine use.

Compliance and Authorship

This article references the STEP-1, STEP-3, STEP-4, SUSTAIN, SELECT, and LEADER clinical trial programs where appropriate. It is intended as patient education and does not replace consultation with a licensed clinician.